These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17496436)

  • 1. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice.
    Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L
    Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of arecoline reduces ethanol-induced sleeping through activation of central muscarinic receptor in mice.
    Sun YP; Liu Q; Luo J; Guo P; Chen F; Lawrence AJ; Liang JH
    Alcohol Clin Exp Res; 2010 Jan; 34(1):150-7. PubMed ID: 19860797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol.
    Alkondon M; Ray A; Sen P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):161-7. PubMed ID: 2865935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nipradilol, a beta-adrenergic blocker with vasodilating activity, on oxotremorine-induced tremor in mice.
    Iwata S; Nomoto M; Fukuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):171-4. PubMed ID: 8962435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta-adrenergic blocking agents, with differing ancillary properties on oxotremorine induced tremor in mice.
    Alkondon M; Ray A; Sen P
    Indian J Exp Biol; 1984 Jul; 22(7):382-3. PubMed ID: 6150896
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.
    Howell G; West L; Jenkins C; Lineberry B; Yokum D; Rockhold R
    BMC Pharmacol; 2005 Aug; 5():13. PubMed ID: 16109168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of zonisamide on experimental tremors in rats.
    Miwa H; Hama K; Kajimoto Y; Kondo T
    Parkinsonism Relat Disord; 2008; 14(1):33-6. PubMed ID: 17587636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.
    Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Korczyn AD
    J Neurol Sci; 2004 Jul; 222(1-2):87-91. PubMed ID: 15240201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peripheral catecholamines in oxotremorine tremor in the rat and its antagonism by beta adrenoceptor blocking agents.
    Weinstock M; Zavadil AP; Rosin AJ; Chiueh CC; Kopin IJ
    J Pharmacol Exp Ther; 1978 Jul; 206(1):91-6. PubMed ID: 26800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The selectivity of the action of muscarinic agonists in vivo].
    Kosmachev AB; Kosmacheva IM; Iankhotova MV; Kuleshov VI
    Eksp Klin Farmakol; 1994; 57(2):6-8. PubMed ID: 8205054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of chlordecone-induced tremor in rats.
    Gerhart JM; Hong JS; Tilson HA
    Neurotoxicology; 1985; 6(1):211-29. PubMed ID: 2581196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by naloxone of the anti-oxotremorine effect of L-DOPA.
    Quock RM; Lucas TS
    Eur J Pharmacol; 1983 Nov; 95(3-4):193-8. PubMed ID: 6653670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of cholinergic tremor by apomorphine and L-dopa in rats.
    Tarchalska-Kryńska B; Gajewska S
    Acta Physiol Pol; 1980; 31(6):669-76. PubMed ID: 7246199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
    Ogren SO; Carlsson S; Bartfai T
    Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparaison, in the mouse, of two treatments for alcohol withdrawal syndrome. Inhibition of oxo tremorine-induced tremor, sedative and motor effects (author's transl)].
    Leinot M; Benoit J; Basiez M; Meunier A; Labrid C
    Ann Pharm Fr; 1979; 37(5-6):205-12. PubMed ID: 44442
    [No Abstract]   [Full Text] [Related]  

  • 19. Device for quantitating tremor activity in mice: antitremor activity of atropine versus soman- and oxotremorine-induced tremors.
    Clement JG; Dyck WR
    J Pharmacol Methods; 1989 Aug; 22(1):25-36. PubMed ID: 2770314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for screening drug and chemical effects in laboratory rats using computerized quantitative electroencephalography.
    Jones RD; Sheets LP; Mueller RE
    Vet Hum Toxicol; 1996 Feb; 38(1):1-7. PubMed ID: 8825739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.